Yearly Archives: "2018"

Abbvie and Biogen pull multiple sclerosis drug Zinbryta following urgent EMA safety review
Seven of the cases were identified in Germany and one in Spain, and included encephalitis and meningoencephalitis. The pharma pair said in [...]
2018 CMSC MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS
MRI is widely used for the early and accurate diagnosis of multiple sclerosis (MS) and is used increasingly in patient follow-up. [...]
Caregivers bill supports patients with multiple sclerosis
President Donald Trump recently signed the Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act (S 1028/HR 3759, [...]
CVS/Aetna combo a formidable pharma rival when it comes to access
Last month's unusual consolidation of healthcare provider CVS Health with insurance company Aetna spawned a new behemoth that could pose a [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM